Weill Cornell Medicine investigators discovered that unique bacteria colonize the gut shortly after birth and make the neurotransmitter serotonin to educate gut immune cells.
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update – Biotech Investments
Issuer: CureVac / Key word(s): Quarterly / Interim Statement 14.11.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac